Both SOX11 and TPX2 showed a trend of increased expression levels with increasing tumor grade, whereas BCL11A did not (Figure 4F ; Additional file 19 ).
← all excerpts
Embryonic mammary signature subsets are activated in Brca1-/- and basal-like breast cancers.
1
—
—